| advertise add site services publishers database health videos | ![]() | about toolbar stats live show health store more stuff JOIN/LOGIN |
Aubrey de Grey at TED Global fightaging.org |
Aubrey David Nicholas Jasper de Grey (born 20 April 1963 in London, England) is an English author and theoretician in the field of gerontology, and the Chief Science Officer of the SENS Foundation. De Grey is the author of the mitochondrial free-radical theory of aging, and the general-audience book Ending Aging, a detailed description of how regenerative medicine may be able to thwart the aging process altogether within a few decades. He works on the development of what he has termed "Strategies for Engineered Negligible Senescence" (SENS) - a tissue-repair strategy intended to rejuvenate the human body and thereby allow an indefinite lifespan. To this end, he has identified seven types of molecular and cellular "damage" caused by essential metabolic processes; SENS is a proposed panel of therapies to repair this damage.[1] The scientific community is skeptical of de Grey's claims; a review of SENS by 28 scientists concluded that none of de Grey's therapies "has ever been shown to extend the lifespan of any organism, let alone humans".[2] De Grey has been interviewed in recent years in many news sources, including CBS 60 Minutes, BBC, the New York Times, Fortune Magazine, the Washington Post, TED, Popular Science and The Colbert Report. His main activities at present are as Chief Science Officer of the SENS Foundation[3] and editor-in-chief of the academic journal Rejuvenation Research.
[edit] EducationAubrey de Grey was educated at Sussex House School and Harrow School. In 1985 he received a B.A. in Computer Science from Trinity Hall, University of Cambridge and joined Sinclair Research Ltd as an AI/software engineer; in 1986, he co-founded Man-Made Minions Ltd[4] to pursue the development of an automated formal program verifier. Until 2006, he was in charge of software development at the University of Cambridge Genetics Department for the FlyBase genetic database. In 2000 Cambridge awarded de Grey a Ph.D.[5] on the basis of his book concerning the biology of one aspect of aging, The Mitochondrial Free Radical Theory of Aging (ISBN 1-58706-155-4), which he wrote in 1999. The book controversially claimed that obviating damage to mitochondrial DNA might by itself extend lifespan significantly, though it stated that it was more likely that cumulative damage to mitochondria is a significant cause of senescence, but not the single dominant cause. A February 8, 2007 search for "de Grey AD [au]" on PubMed[6] revealed 61 publications in 25 peer-reviewed journals, of which 19 are in Rejuvenation Research (impact factor 4.728), the journal edited by de Grey. [edit] StrategiesDe Grey argues that the fundamental knowledge needed to develop effective anti-aging medicine mostly already exists, and that the science is ahead of the funding. He works to identify and promote specific technological approaches to the reversal of various aspects of aging, or as de Grey puts it, "the set of accumulated side effects from metabolism that eventually kills us,"[7] and for the more proactive and urgent approaches to extending the healthy human lifespan. Regarding this issue, de Grey is a supporter of life extension. As of 2005, his work centered upon a detailed plan called Strategies for Engineered Negligible Senescence (SENS), which is aimed at preventing age-related physical and cognitive decline. In March 2009, Aubrey de Grey co-founded the SENS Foundation, a non-profit organization based in California, United States, where he currently serves as Chief Science Officer. The Foundation "works to develop, promote and ensure widespread access to regenerative medicine solutions to the disabilities and diseases of aging,"[8] focusing on the Strategies for Engineered Negligible Senescence. De Grey is also co-founder (with David Gobel) and former Chief Scientist of the Methuselah Foundation, a 501(c)(3) nonprofit organization based in Springfield, Virginia, United States. A major activity of the Methuselah Foundation is the Methuselah Mouse Prize,[9] a prize designed to hasten the research into effective life extension interventions by awarding monetary prizes to researchers who stretch the lifespan of mice to unprecedented lengths. Regarding this, de Grey stated in March 2005 "if we are to bring about real regenerative therapies that will benefit not just future generations, but those of us who are alive today, we must encourage scientists to work on the problem of aging." The prize reached 4.2 USD million in February 2007. De Grey believes that once dramatic life extension of already middle-aged mice has been achieved, a large amount of funding will be diverted to this kind of research, which would accelerate progress in doing the same for humans. De Grey has published papers in this area in prominent journals with some of biogerontology's foremost researchers, including Bruce Ames, Leonid Gavrilov and S. Jay Olshansky, as well as other thinkers such as Gregory Stock.[10] He has also received support from other prominent scientists, such as William Haseltine, the biotech pioneer of Human Genome Sciences, who in March 2005 stated regarding the Methuselah Mouse Prize "there’s nothing to compare with this effort, and it has already contributed significantly to the awareness that regenerative medicine is a near term reality, not an if."[11] In 2005, he was the subject of a critical article in MIT's Technology Review.[10] See de Grey Technology Review controversy. In 2007, de Grey wrote the book "Ending Aging" with the assistance of Michael Rae.[12] It summarizes the science, politics and social challenges of the entire SENS agenda.[13] In a 2008 broadcast[14] on the Arte German & French TV, de Grey confirmed that according to him, the first human who will live up to 1,000 years is probably already alive now, and might even be today between 50 and 60 years old. [edit] The seven types of aging damage proposed by de GreyMain article: Strategies for Engineered Negligible Senescence
[edit] Technology Review debateMain article: De Grey Technology Review debate A debate over the validity of the de Grey's theories on ageing was published in MIT's Technology Review. In the end, none of the challengers to de Grey were able to convince the judges that SENS was "so wrong that it is unworthy of learned debate." [edit] Scientific journal
[edit] Titles and positionsDe Grey is a fellow of the Institute for Ethics and Emerging Technologies[15] and an advisor for the Singularity Institute.[16] [edit] Recorded public appearances[edit] Talks[edit] 2009[edit] 2008
[edit] 2007
[edit] 2006
[edit] 2005
[edit] 2003[edit] TV interviews
[edit] Radio, podcast, and video podcast interviews
[edit] Film appearances
[edit] Quote
[edit] See also[edit] References
[edit] External links
| |||||||||||||||||||
| ↑ top of page ↑ | about thumbshots |